Form 4: AnaptysBio Director Hollings Renton Executes Stock Transactions

Director Hollings Renton of AnaptysBio, Inc. reports the acquisition and disposal of common stock and restricted stock units.

Summary

• On June 15, 2024, Hollings Renton acquired 3,900 shares of common stock through the vesting of restricted stock units (RSUs).
• The RSUs converted into common stock at a price of $0 per share.
• On June 18, 2024, Renton sold 1,950 shares of common stock at a price of $23.16 per share.
• The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2024.
• Following these transactions, Renton directly owns 1,950 shares of AnaptysBio common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports stock transactions by a company director, which is a routine occurrence. There is no indication of positive or negative implications for the company's performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders (officers, directors, or those holding more than 10% of a company's shares) trade in their company's stock. These filings provide transparency to the market regarding insider activity.

Stakeholder Impact

• The transactions may be of interest to shareholders as they provide insight into the actions of a company insider.

Key Dates